Business

Merck’s Covid Pill Cleared by FDA for High-Risk Adults – The New York Times

Merck has not yet released findings from company laboratory experiments on how well the drug can stop the Omicron variant from replicating. But the drug is designed to work in a way that makes scient… [+1764 chars]

View The Article On: New York Times

Powered By NewsAPI.org

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top